Who is sponsoring NCT07233551?

NCT07233551 is sponsored by Assiut University.

What drugs are being tested in NCT07233551?

Interventions in NCT07233551: CBC derived inflammatory indices.

What condition does NCT07233551 study?

NCT07233551 studies Acute Pancreatitis (AP), Inflammatory Indices.

Is NCT07233551 still recruiting?

NCT07233551 is currently not yet recruiting. Last updated 18 November 2025.

Last reviewed 2025-11-18 · How we verify

NCT07233551

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Utilization of CBC-Derived Inflammatory Indices in Assessing Severity and Prognosis of Acute Pancreatitis.

Not yet recruiting Last updated 18 November 2025

What this trial tests

trial testing CBC derived inflammatory indices in Acute Pancreatitis (AP) in 100 participants. Not yet recruiting.

Timeline

1 December 2025

Primary endpoint
30 November 2026

30 December 2026

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 December 2025
Primary completion	30 November 2026
Estimated completion	30 December 2026

Drugs / interventions tested

CBC derived inflammatory indices

Conditions studied

Acute Pancreatitis (AP) — all drugs for Acute Pancreatitis (AP) →
Inflammatory Indices — all drugs for Inflammatory Indices →

Sponsor

Assiut University

Who can join

18 and older, any sex, with Acute Pancreatitis (AP) or Inflammatory Indices. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Utilization of CBC-Derived Inflammatory Indices in Assessing Severity and Prognosis of Acute Pancreatitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Pancreatitis (AP)

Currently open trials in the same condition.

NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
NCT06867120 — Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study · recruiting
NCT06835023 — Dextran 40 Plus Ringer's Lactate Vs. Ringer's Lactate Alone for Fluid Resuscitation in Acute Pancreatitis · NA · recruiting
NCT07450898 — Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disor · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07233551 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 18 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07233551.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing